In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Syros Pharmaceuticals Inc (NASDAQ: SYRS) closed the day trading at $0.16 down -5.99% from the previous closing price of $0.17. In other words, the price has decreased by -$5.99 from its previous closing price. On the day, 1.26 million shares were traded.
Ratios:
For a better understanding of SYRS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.25 and its Current Ratio is at 2.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 04, 2020, Upgraded its rating to Buy and sets its target price to $15 from $11 previously.
On September 22, 2020, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 27 ’24 when Flagship Pioneering Fund VII, bought 1,135,308 shares for $0.24 per share.
AKKARAJU SRINIVAS bought 9,333 shares of SYRS for $2,306 on Dec 30 ’24. On Dec 27 ’24, another insider, Flagship Pioneering Fund VII, , who serves as the Affiliate of the company, bought 1,331,624 shares for $0.21 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.80.
Stock Price History:
Over the past 52 weeks, SYRS has reached a high of $7.96, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -22.53%, while the 200-Day Moving Average is calculated to be -93.80%.
Shares Statistics:
A total of 26.83M shares are outstanding, with a floating share count of 23.67M. Insiders hold about 11.80% of the company’s shares, while institutions hold 8.27% stake in the company.
